BBOT
Price
$11.55
Change
+$0.30 (+2.67%)
Updated
Oct 21, 10:34 AM (EDT)
Capitalization
890.96M
43 days until earnings call
Intraday Buy/Sell Signals
PRTC
Price
$18.36
Change
+$0.18 (+0.99%)
Updated
Oct 21, 10:30 AM (EDT)
Capitalization
429.55M
43 days until earnings call
Intraday Buy/Sell Signals
Interact to see
Advertisement

BBOT vs PRTC

Header iconBBOT vs PRTC Comparison
Open Charts BBOT vs PRTCBanner chart's image
BridgeBio Oncology Therapeutics
Price$11.55
Change+$0.30 (+2.67%)
Volume$100
Capitalization890.96M
PureTech Health
Price$18.36
Change+$0.18 (+0.99%)
Volume$270
Capitalization429.55M
BBOT vs PRTC Comparison Chart in %
BBOT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
PRTC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
BBOT vs. PRTC commentary
Oct 21, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BBOT is a Hold and PRTC is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Oct 21, 2025
Stock price -- (BBOT: $11.25 vs. PRTC: $18.18)
Brand notoriety: BBOT and PRTC are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: BBOT: 26% vs. PRTC: 69%
Market capitalization -- BBOT: $890.96M vs. PRTC: $429.55M
BBOT [@Biotechnology] is valued at $890.96M. PRTC’s [@Biotechnology] market capitalization is $429.55M. The market cap for tickers in the [@Biotechnology] industry ranges from $107.45B to $0. The average market capitalization across the [@Biotechnology] industry is $2.05B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

BBOT’s FA Score shows that 1 FA rating(s) are green whilePRTC’s FA Score has 1 green FA rating(s).

  • BBOT’s FA Score: 1 green, 4 red.
  • PRTC’s FA Score: 1 green, 4 red.
According to our system of comparison, PRTC is a better buy in the long-term than BBOT.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

BBOT’s TA Score shows that 6 TA indicator(s) are bullish while PRTC’s TA Score has 5 bullish TA indicator(s).

  • BBOT’s TA Score: 6 bullish, 3 bearish.
  • PRTC’s TA Score: 5 bullish, 5 bearish.
According to our system of comparison, BBOT is a better buy in the short-term than PRTC.

Price Growth

BBOT (@Biotechnology) experienced а -1.83% price change this week, while PRTC (@Biotechnology) price change was +3.14% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +7.94%. For the same industry, the average monthly price growth was +22.13%, and the average quarterly price growth was +71.28%.

Reported Earning Dates

BBOT is expected to report earnings on Dec 03, 2025.

PRTC is expected to report earnings on Dec 03, 2025.

Industries' Descriptions

@Biotechnology (+7.94% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
BBOT($891M) has a higher market cap than PRTC($430M). BBOT YTD gains are higher at: 7.143 vs. PRTC (-1.517). PRTC has higher annual earnings (EBITDA): 37.8M vs. BBOT (-94.43M). PRTC has more cash in the bank: 322M vs. BBOT (131M). BBOT has less debt than PRTC: BBOT (2.83M) vs PRTC (20.9M). PRTC has higher revenues than BBOT: PRTC (6.17M) vs BBOT (0).
BBOTPRTCBBOT / PRTC
Capitalization891M430M207%
EBITDA-94.43M37.8M-250%
Gain YTD7.143-1.517-471%
P/E RatioN/A10.69-
Revenue06.17M-
Total Cash131M322M41%
Total Debt2.83M20.9M14%
TECHNICAL ANALYSIS
Technical Analysis
BBOTPRTC
RSI
ODDS (%)
N/A
Bearish Trend 5 days ago
86%
Stochastic
ODDS (%)
Bullish Trend 5 days ago
38%
Bullish Trend 5 days ago
81%
Momentum
ODDS (%)
Bearish Trend 5 days ago
11%
Bearish Trend 5 days ago
83%
MACD
ODDS (%)
Bearish Trend 5 days ago
12%
Bearish Trend 5 days ago
73%
TrendWeek
ODDS (%)
Bearish Trend 5 days ago
14%
Bullish Trend 5 days ago
78%
TrendMonth
ODDS (%)
Bullish Trend 5 days ago
29%
Bullish Trend 5 days ago
77%
Advances
ODDS (%)
Bullish Trend 20 days ago
35%
Bullish Trend 7 days ago
79%
Declines
ODDS (%)
Bearish Trend 5 days ago
29%
Bearish Trend 15 days ago
82%
BollingerBands
ODDS (%)
Bullish Trend 5 days ago
9%
Bullish Trend 6 days ago
84%
Aroon
ODDS (%)
Bullish Trend 5 days ago
14%
Bearish Trend 5 days ago
82%
View a ticker or compare two or three
Interact to see
Advertisement
BBOT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
PRTC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
RYHEX117.951.56
+1.34%
Rydex Health Care A
FOCIX14.300.09
+0.63%
Fairholme Focused Income
MKVFX17.070.02
+0.12%
MFS International Large Cap Value R3
CHDEX14.40N/A
N/A
Cullen High Dividend Equity Retail
FJACX11.35N/A
N/A
Fidelity Series Small Cap Discovery

BBOT and

Correlation & Price change

A.I.dvisor tells us that BBOT and VKTX have been poorly correlated (+25% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that BBOT and VKTX's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To BBOT
1D Price
Change %
BBOT100%
+0.90%
VKTX - BBOT
25%
Poorly correlated
+0.64%
COCP - BBOT
25%
Poorly correlated
+1.87%
PRTC - BBOT
22%
Poorly correlated
+1.00%
RAPP - BBOT
22%
Poorly correlated
+5.76%
VTGN - BBOT
21%
Poorly correlated
+10.62%
More

PRTC and

Correlation & Price change

A.I.dvisor tells us that PRTC and IRON have been poorly correlated (+32% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that PRTC and IRON's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To PRTC
1D Price
Change %
PRTC100%
+1.00%
IRON - PRTC
32%
Poorly correlated
-3.08%
RLMD - PRTC
31%
Poorly correlated
+12.44%
ZLAB - PRTC
30%
Poorly correlated
+1.59%
PTCHF - PRTC
29%
Poorly correlated
N/A
AUTL - PRTC
28%
Poorly correlated
+4.94%
More